ENZO BIOCHEM INC (ENZ) Institutional Ownership
None of the superinvestors we track currently report ENZO BIOCHEM INC (ENZ) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in ENZO BIOCHEM INC (ENZ), this page will show disclosed ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q1 2025 | 1 | $770,425 | 2,082,229 |
| Q4 2024 | 1 | $1,691,136 | 2,367,543 |
| Q3 2024 | 1 | $2,830,832 | 2,527,529 |
| Q2 2024 | 1 | $2,724,505 | 2,499,546 |
| Q1 2024 | 1 | $3,093 | 2,435,129 |
| Q4 2023 | 1 | $3,446 | 2,479,195 |
| Q3 2023 | 1 | $3,578 | 2,556,064 |
| Q2 2023 | 1 | $4,977 | 2,704,864 |
| Q1 2023 | 1 | $6,731 | 2,770,064 |
| Q4 2022 | 1 | $4,024 | 2,813,964 |
| Q3 2022 | 1 | $6,489 | 2,909,664 |
| Q2 2022 | 1 | $6,243 | 3,016,164 |
Related ENZ Institutional Insights:
- ENZ Institutional Ownership & Insiders Activity
- ENZ Institutional Ownership & 13F Activity
- ENZ Top Institutional Shareholders
- ENZ Institutional Buying Activity
- ENZ Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- ENZ Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings